Literature DB >> 2729956

Liposomes of enviroxime and phosphatidylcholine: definition of the drug-phospholipid interactions.

N M Garcon1, H R Six, J Frazer, C Hazlewood, B E Gilbert, V Knight.   

Abstract

Interaction of the antiviral compound, enviroxime (E), with natural and synthetic phosphatidylcholines in organic and aqueous media was studied. Although insoluble in chloroform, E dissolved in chloroform solutions containing phosphatidylcholines. Solvation was directly related to the length of the fatty acid chains of the phospholipid. Proton spin resonance studies suggested an interaction of the fatty acid chains with the aromatic rings of E. Suspension of E-phosphatidylcholine mixtures of molar ratios up to 0.7:1.0 in aqueous media resulted in the formation of multilamellar liposomes. Liposomes containing E were more stable permeability barriers than those prepared with phospholipid alone, a property previously observed with cholesterol. Competition experiments suggested that E bound to the same sites in lipid bilayers as does cholesterol. These data indicate that E is incorporated into lipid bilayers of liposomes and that it alters the physical properties of the liposomes in a manner similar to that of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729956     DOI: 10.1016/0166-3542(89)90011-9

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  2 in total

1.  Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.

Authors:  B E Gilbert; P R Wyde; G Lopez-Berestein; S Z Wilson
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

2.  Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice.

Authors:  B E Gilbert; P R Wyde; S Z Wilson
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.